Corpus Intelligence IC Memo — ALTA VISTA REGIONAL HOSPITAL 2026-04-26 12:05 UTC
IC Memo — ALTA VISTA REGIONAL HOSPITAL
Investment Committee Memorandum | NM | 46 beds | Grade D | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ALTA VISTA REGIONAL HOSPITAL

CCN 320003 | SAN MIGUEL, NM | 46 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ALTA VISTA REGIONAL HOSPITAL is a 46-bed community hospital in SAN MIGUEL, NM with $21.7M in net patient revenue and a -33.6% operating margin. The hospital serves a payer mix of 39.2% Medicare, 0.0% Medicaid, and 60.8% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -33.6% to -26.3% (+736bps).

Net Revenue HCRIS$21.7M
Current EBITDA COMPUTED$-7.3M
Operating Margin COMPUTED-33.6%
Occupancy HCRIS9.4%
Revenue / Bed COMPUTED$471K
Net-to-Gross HCRIS17.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

55
NM Hospitals
-2.7%
State Median Margin
34
Comparable Hospitals

NM has 55 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of -33.6% places it below the state median. Among 34 size-comparable peers (23-92 beds), the median margin is -2.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (23-92), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ALTA VISTA REGIONAL HOSPITAL (Target)NM46$21.7M-33.6%
GERALD CHAMPION REGIONAL MEDICNM66$245.9M-11.6%
NOR-LEA HOSPITALNM25$131.5M0.9%
UNM SANDOVAL REGIONAL MEDICAL NM60$104.5M-11.9%
CARLSBAD MEDICAL CENTERNM53$97.1M19.9%
SANTA FE MEDICAL CENTERNM36$95.0M-26.5%
ESPANOLA HOSPITALNM70$84.1M-2.3%
GILA REGIONAL MEDICAL CENTERNM25$83.6M-3.6%
HOLY CROSS HOSPITALNM25$72.9M-20.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$455K+210bp18mo
Cost to Collect4.5%2.5%$433K+200bp12mo
Denial Rate Reduction12.0%6.5%$429K+198bp12mo
A/R Days Reduction5200.0%3800.0%$263K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$455K
Cost to Collect
$433K
Denial Rate Reduction
$429K
A/R Days Reduction
$263K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$-7.3M
+ RCM Uplift+$1.6M
Pro Forma EBITDA$-5.7M
Current Margin-33.6%
Pro Forma Margin-26.3%
WC Released (1x)$831K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-11.2M$-32.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-11.2M$-39.0M0.00x-100.0%
Bull Case9.0x11.0x$-10.1M$-37.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-10.1M$-43.7M0.00x-100.0%
Bear Case11.0x10.0x$-12.3M$-36.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-12.3M$-44.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 9.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 23-92 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-18.8% / P50=-2.3% / P75=8.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.